Literature DB >> 3790978

Cerebellar haemangioblastoma and von Hippel-Lindau disease.

S M Huson, P S Harper, M D Hourihan, G Cole, R D Weeks, D A Compston.   

Abstract

Von Hippel-Lindau disease is an autosomal dominant multisystem disorder, the commonest presenting manifestations of which are haemangioblastomas of the cerebellum and retina. Affected individuals are at risk of developing a number of other lesions, the most serious of which are renal carcinoma, haemangioblastomas elsewhere in the central nervous system and phaeochromocytoma. Patients with this disease can therefore present to a number of disciplines during their lifetime and unless the possibility of von Hippel-Lindau disease is considered, the patient may wrongly be assumed to have an isolated lesion. Twenty patients with cerebellar haemangioblastomas were seen between 1972 and 1985; the diagnosis of von Hippel-Lindau disease was subsequently established in 8. Although the diagnosis had not previously been considered, in retrospect 7/8 cases were known to be at risk of this syndrome. These cases came from 7 families and an additional 4 relatives are also known to have been affected. Mean age of presentation for the various manifestations of von Hippel-Lindau disease, each of which occurred in one or other of our cases, has been calculated from 9 of our patients and 107 others reported in the literature. Clinically significant manifestations almost invariably developed before the age of 50 years. Limited screening of our index cases and their at-risk relatives demonstrated one asymptomatic renal carcinoma. We propose a protocol for screening all individuals at risk of von Hippel-Lindau disease, which involves annual retinal examination from five years, and biennial computerized tomography of the head and abdomen from fifteen and twenty years, respectively.

Entities:  

Mesh:

Year:  1986        PMID: 3790978     DOI: 10.1093/brain/109.6.1297

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  18 in total

1.  A regional register for inherited cancers.

Authors:  M Littler; P S Harper
Journal:  BMJ       Date:  1989-06-24

2.  A genetic register for von Hippel-Lindau disease.

Authors:  I R Maddock; A Moran; E R Maher; M D Teare; A Norman; S J Payne; R Whitehouse; C Dodd; M Lavin; N Hartley; M Super; D G Evans
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

3.  Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.

Authors:  F J Hes; S McKee; M J Taphoorn; P Rehal; R B van Der Luijt; R McMahon; J J van Der Smagt; D Dow; R A Zewald; J Whittaker; C J Lips; F MacDonald; P L Pearson; E R Maher
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

4.  Surgical decision-making affected by clinical and genetic screening of a novel kindred with von Hippel-Lindau disease and pancreatic islet cell tumors.

Authors:  S A Curley; S T Lott; J W Luca; M L Frazier; A M Killary
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

5.  Central nervous system haemangioblastoma: a clinical and genetic study of 52 cases.

Authors:  A M Boughey; N A Fletcher; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

6.  Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.

Authors:  B R Seizinger; D I Smith; M R Filling-Katz; H Neumann; J S Green; P L Choyke; K M Anderson; R N Freiman; S M Klauck; J Whaley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.

Authors:  E R Maher; J R Yates; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

8.  Genetic mapping of dinucleotide repeat polymorphisms and von Hippel-Lindau disease on chromosome 3p25-26.

Authors:  M A Pericak-Vance; K J Nunes; E Whisenant; D B Loeb; K W Small; J M Stajich; J B Rimmler; L H Yamaoka; D I Smith; H A Drabkin
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

9.  Surgical management of haemangioblastoma of the posterior fossa.

Authors:  L Symon; T Murota; M Pell; L Bordi
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

10.  Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Authors:  J M Whaley; J Naglich; L Gelbert; Y E Hsia; J M Lamiell; J S Green; D Collins; H P Neumann; J Laidlaw; F P Li
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.